Tesla shares rose after results and it disclosed a 2 billion dollar xAI investment, Forbes wrote. A positive stock reaction is colliding with weak annual revenue, forcing a near term narrative pricing constraint.
Tesla is reframing a weak revenue milestone into an AI and robotics narrative, and early trading shows investors are rewarding the story while scrutinizing capital intensity.
Before this shift, Tesla was valued as an EV maker with autonomy promises. That setup rewarded story upgrades until investors demanded returns as spending climbed. The Forbes report says Tesla posted its first annual revenue decline. It also says the quarter narrowly beat forecasts.
Forbes notes the xAI investment proposal previously received a lukewarm investor response. Tesla disclosed a 2 billion dollar investment in xAI after reporting results. Tesla shares rose in early trading and Tesla shares rose 1.8% in Frankfurt. A prior AI capex shock at Alphabet left shares down about 8% on Feb. 5, 2025, as Investing.com carried the Reuters dispatch. On the Q4 2025 earnings call, CEO Elon Musk framed the spend pressure as “This is going to be a very big capex year. We’re making big investments for an epic future.” while speaking with TimesLIVE republishing Reuters.
A positive stock reaction sits alongside negative annual revenue news, and Tesla disclosed 2 billion dollars for xAI. The same contradiction leaves the share move tied to what Reuters framed as pared gains. Musk said Tesla will end Model S and Model X production while shifting Fremont lines. When AI stories dominate, investors demand evidence of returns as capex rises quickly. A Tesla exposed ETF manager described a business model transition while the stock rose.
That manager’s framing fits a setup where narrative can outrun near term auto fundamentals. The Alphabet capex episode showed shares can drop when spending looks aggressive versus profit visibility. Tesla’s after hours gains pared after capital expenditure plan details surfaced. Reuters noted Cybercab robotaxi production plans were on track for this year while capex sensitivity stayed visible. Meta style tech valuation comparisons were not disclosed, leaving the market to price optionality directly.
The exact timing and operational plan for ending Model S and Model X production remains unspecified. The full terms, governance, and commercial rationale of the xAI investment remain unclear. Stated goals like 1 million Optimus robots constrain how far valuation can extend. Missing guidance constrains any margin math for Cybercab or Optimus adoption. Reuters framed the stock as trading like major tech peers while funding needs stay central. Whether capex disclosure cadence, xAI governance detail, and Cybercab unit economics arrive will shape the next one to three quarters.
